We focus on the treatment of malignancies and benign diseases in the hepato-biliary-pancreatic field. In addition, we offer splenectomy and partial splenic embolization for patients with hematologic diseases and portal hypertension.
Our department is recognized as one of the most aggressive surgical teams and leads the world in the field of hepato-biliary-pancreatic surgery. In particular, our therapeutic management and operation for hilar cholangiocarcinoma is famous worldwide.
We accept outpatients on Mondays, Wednesdays, and Fridays. No reservation is needed for the consultation.
Hepatocellular carcinoma, intrahepatic cholangiocarcinoma, metastatic liver tumors, other malignant tumors and benign diseases.
Cholangiocarcinoma, cancer of the papilla vater, duodenal cancer, gallbladder cancer, choledocholithiasis, cholecystolithiasis, other malignant tumors and benign diseases.
Pancreatic cancer, intraductal papillary mucinous neoplasma, mucinous cystic neoplasma, acute & chronic pancreatitis, other malignant tumors and benign diseases.
Hematologic diseases like ITP, portal hypertension, splenomegaly, and other diseases.
Liver failure, HCC, and other diseases.
|Associate Professors||Hideyuki Yoshitomi||Katsunori Furukawa|
|Tsukasa Takayashiki||Satoshi Kuboki|
|Staff||Shigetsugu Takano||Daisuke Suzuki|
|Nozomu Sakai||Shingo Kagawa|
|Hiroyuki Nojima||Takashi Mishima|